134 related articles for article (PubMed ID: 4020835)
1. Synthesis and antineoplastic evaluations of 5,8-bis[(aminoalkyl)amino]-1-azaanthracene-9,10-diones.
Krapcho AP; Landi JJ; Hacker MP; McCormack JJ
J Med Chem; 1985 Aug; 28(8):1124-6. PubMed ID: 4020835
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activities of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and related systems.
Krapcho AP; Landi JJ; Shaw KJ; Phinney DG; Hacker MP; McCormack JJ
J Med Chem; 1986 Aug; 29(8):1370-3. PubMed ID: 3735305
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones as potential antileukemic agents.
Stefanska B; Dzieduszycka M; Martelli S; Borowski E
J Med Chem; 1989 Aug; 32(8):1724-8. PubMed ID: 2754697
[TBL] [Abstract][Full Text] [Related]
4. Heterosubstituted anthracene-9,10-dione analogues. The synthesis and antitumor evaluation of 5,8-bis[(aminoalkyl)amino]naphtho[2,3-b] thiophene-4,9-diones.
Krapcho AP; Petry ME; Hacker MP
J Med Chem; 1990 Sep; 33(9):2651-5. PubMed ID: 2391703
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor evaluations of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-diones.
Krapcho AP; Getahun Z; Avery KL; Vargas KJ; Hacker MP; Spinelli S; Pezzoni G; Manzotti C
J Med Chem; 1991 Aug; 34(8):2373-80. PubMed ID: 1875336
[TBL] [Abstract][Full Text] [Related]
6. 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: synthesis and antitumor evaluations.
Krapcho AP; Petry ME; Getahun Z; Landi JJ; Stallman J; Polsenberg JF; Gallagher CE; Maresch MJ; Hacker MP; Giuliani FC
J Med Chem; 1994 Mar; 37(6):828-37. PubMed ID: 8145234
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, peroxidating ability, and antineoplastic evaluation of 1-[(aminoalkyl)amino]-4-hydroxy-10-imino-9-anthracenones.
Dzieduszycka M; Martelli S; Tarasiuk J; Paradziej-Lukowicz J; Borowski E
J Med Chem; 1991 Feb; 34(2):541-6. PubMed ID: 1995874
[TBL] [Abstract][Full Text] [Related]
8. Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
Murdock KC; Child RG; Fabio PF; Angier RB; Wallace RE; Durr FE; Citarella RV
J Med Chem; 1979 Sep; 22(9):1024-30. PubMed ID: 490545
[TBL] [Abstract][Full Text] [Related]
9. 2,2-Dimethyl-2H-anthra[2,3-b]pyran-6,11-diones: a new class of cytotoxic compounds.
Melliou E; Magiatis P; Mitaku S; Skaltsounis AL; Pierré A; Atassi G; Renard P
Bioorg Med Chem; 2001 Mar; 9(3):607-12. PubMed ID: 11310594
[TBL] [Abstract][Full Text] [Related]
10. 1,4-disubstituted anthracene antitumor agents.
Iyengar BS; Dorr RT; Alberts DS; Sólyom AM; Krutzsch M; Remers WA
J Med Chem; 1997 Nov; 40(23):3734-8. PubMed ID: 9371238
[TBL] [Abstract][Full Text] [Related]
11. 8,11-dihydroxy-6-[(aminoalkyl)amino]-7H-benzo[e]perimidin-7-ones with activity in multidrug-resistant cell lines: synthesis and antitumor evaluation.
Stefańska B; Dzieduszycka M; Bontemps-Gracz MM; Borowski E; Martelli S; Supino R; Pratesi G; De Cesare M; Zunino F; Kuśnierczyk H; Radzikowski C
J Med Chem; 1999 Sep; 42(18):3494-501. PubMed ID: 10479282
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones.
Antonini I; Santoni G; Lucciarini R; Amantini C; Dal Ben D; Volpini R; Cristalli G
J Med Chem; 2008 Feb; 51(4):997-1006. PubMed ID: 18232651
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of pyrido-amsacrine analogues and related compounds.
Llama E; Del Campo C; Capo M; Anadon M
J Pharm Sci; 1993 Mar; 82(3):262-5. PubMed ID: 8450419
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-tumor activity of new steroidal nuclear analogues of aragusterol A.
Mitome H; Shinohara M; Miyaoka H; Yamada Y
Chem Pharm Bull (Tokyo); 2003 Jun; 51(6):640-5. PubMed ID: 12808239
[TBL] [Abstract][Full Text] [Related]
15. 1,2-Bis(sulfonyl)hydrazines. 3. Effects of structural modification on antineoplastic activity.
Shyam K; Hrubiec RT; Furubayashi R; Cosby LA; Sartorelli AC
J Med Chem; 1987 Nov; 30(11):2157-61. PubMed ID: 3669023
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic agents. 1. Synthesis and antineoplastic activities of chloroethyl- and methylnitrosourea analogues of thymidine.
Lin TS; Fischer PH; Shiau GT; Prusoff WH
J Med Chem; 1978 Jan; 21(1):130-3. PubMed ID: 563461
[TBL] [Abstract][Full Text] [Related]
17. Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias.
Showalter HD; Johnson JL; Hoftiezer JM; Turner WR; Werbel LM; Leopold WR; Shillis JL; Jackson RC; Elslager EF
J Med Chem; 1987 Jan; 30(1):121-31. PubMed ID: 3806589
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic evaluation of novel thiazolocarbazoles.
Lamazzi C; Chabane H; Thiery V; Pierre A; Leonce S; Pfeiffer B; Renard P; Guillaumet G; Besson T
J Enzyme Inhib Med Chem; 2002 Dec; 17(6):397-401. PubMed ID: 12683675
[TBL] [Abstract][Full Text] [Related]
19. 6-[(aminoalkyl)amino]-substituted 7H-benzo[e]perimidin-7-ones as novel antineoplastic agents. Synthesis and biological evaluation.
Stefańska B; Dzieduszycka M; Martelli S; Tarasiuk J; Bontemps-Gracz M; Borowski E
J Med Chem; 1993 Jan; 36(1):38-41. PubMed ID: 8421288
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxic activity against L1210 leukemia of new aminocyclopenta[c]thiophenones.
Alsaidi A; al Shargapi S; Dallemagne P; Carreiras F; Gauduchon P; Rault S; Robba M
Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1605-8. PubMed ID: 7954912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
